Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 5395-5402

  Guo, Sien ^a   Chen, Wenjie ^a   Luo, Yihuan ^a   Ren, Fanghui ^a   Zhong, Tengfei ^a   Rong, Minhua ^b   Dang, Yiwu ^a   Feng, Zhenbo ^a   Chen, Gang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; NEAT1; Tumorigenesis

Indexed keywords

LONG UNTRANSLATED RNA; NEAT1 LONG NON-CODING RNA, HUMAN;

ADULT; AGED; CANCER STAGING; CARCINOGENESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RNA, LONG NONCODING;

EID: 84937781061     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ma L, Chua MS, Andrisani O and So S. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol 2014; 20: 333-45.
2. Lafaro KJ, Demirjian AN and Pawlik TM. Epidemiology of Hepatocellular Carcinoma. Surg Oncol Clin N Am 2015; 24: 1-17.
3. Taura N, Fukushima N, Yastuhashi H, Takami Y, Seike M, Watanabe H, Mizuta T, Sasaki Y, Nagata K, Tabara A, Komorizono Y, Taketomi A, Matsumoto S, Tamai T, Muro T, Nakao K, Fukuizumi K, Maeshiro T, Inoue O and Sata M. The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area. Med Sci Monit 2011; 17: Ph7-11.
4. El-Serag HB and Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76.
5. Hou W and Bonkovsky HL. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy. World J Gastroenterol 2013; 19: 7836-45.
6. Kretzer IF, do Livramento A, da Cunha J, Goncalves S, Tosin I, Spada C and Treitinger A. Hepatitis C worldwide and in Brazil: silent epidemic-data on disease including incidence, transmission, prevention, and treatment. ScientificWorldJournal 2014; 2014: 827849.
7. Amr S, Iarocci EA, Nasr GR, Saleh D, Blancato J, Shetty K and Loffredo CA. Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women. BMC Cancer 2014; 14: 893.
8. Zhang H, Chen Z, Wang X, Huang Z, He Z and Chen Y. Long non-coding RNA: a new player in cancer. J Hematol Oncol 2013; 6: 37.
9. Malek E, Jagannathan S and Driscoll JJ. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 2014; 5: 8027-38.
10. Mizrahi I, Mazeh H, Grinbaum R, Beglaibter N, Wilschanski M, Pavlov V, Adileh M, Stojadinovic A, Avital I, Gure AO, Halle D and Nissan A. Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach. J Cancer 2015; 6: 105-10.
11. Ding C, Cheng S, Yang Z, Lv Z, Xiao H, Du C, Peng C, Xie H, Zhou L, Wu J and Zheng S. Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells. Int J Mol Sci 2014; 15: 4060-76.
12. Gao W, Chan JY and Wong TS. Long non-coding RNA deregulation in tongue squamous cell carcinoma. Biomed Res Int 2014; 2014: 405860.
13. Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jockel KH, Kollmeier J and Bruning T. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes 2013; 6: 518.
14. Pan YF, Qin T, Feng L and Yu ZJ. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma. J Huazhong Univ Sci Technolog Med Sci 2013; 33: 96-101.
15. Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, Sugimachi K, Mimori K, Wakabayashi G and Mori M. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep 2013; 29: 946-50.
16. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM and Zheng SS. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012; 29: 1810-6.
17. Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcino-genesis 2013; 34: 577-86.
18. Naganuma T and Hirose T. Paraspeckle formation during the biogenesis of long non-coding RNAs. RNA Biol 2013; 10: 456-61.
19. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A and Lawrence JB. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 2009; 33: 717-26.
20. Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S, Brown CJ and Lam WL. Human cancer long non-coding RNA transcrip-tomes. PLoS One 2011; 6: e25915.
21. Zhao W, An Y, Liang Y and Xie XW. Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer. Eur Rev Med Pharmacol Sci 2014; 18: 1930-6.
22. Rong M, He R, Dang Y and Chen G. Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. Ups J Med Sci 2014; 119: 19-24.
23. Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, Dewaele A, Sadones J, Geers C and De Greve J. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One 2013; 8: e60317.
24. Dang YW, Zeng J, He RQ, Rong MH, Luo DZ and Chen G. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac J Cancer Prev 2014; 15: 4969-76.
25. Fang TT, Sun XJ, Chen J, Zhao Y, Sun RX, Ren N and Liu BB. Long Non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential. Asian Pac J Cancer Prev 2014; 15: 10513-124.
26. Tu ZQ, Li RJ, Mei JZ and Li XH. Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol 2014; 7: 4303-9.
27. Kim YS, Hwan JD, Bae S, Bae DH and Shick WA. Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma. BMC Cancer 2010; 10: 576.
28. Zeng C, Xu Y, Xu L, Yu X, Cheng J, Yang L, Chen S and Li Y. Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells. BMC Cancer 2014; 14: 693.
29. Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M, MacDonald TY, Fontugne J, Erho N, Vergara IA, Ghadessi M, Davicioni E, Jenkins RB, Palanisamy N, Chen Z, Nakagawa S, Hirose T, Bander NH, Beltran H, Fox AH, Elemento O and Rubin MA. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 2014; 5: 5383.
30. Choudhry H, Albukhari A, Morotti M, Hider S, Moralli D, Smythies J, Schodel J, Green CM, Camps C, Buffa F, Ratcliffe P, Ragoussis J, Harris AL and Mole DR. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2alpha dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene 2014; [Epub ahead of print].
31. Ahn S, Hyeon J and Park CK. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy. Gut Liver 2013; 7: 206-12.
32. Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J and Zhou J. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2011; 17: 7294-302.
33. Lee MJ, Xu DY, Li H, Yu GR, Leem SH, Chu IS, Kim IH and Kim DG. Pro-oncogenic potential of NM23-H2 in hepatocellular carcinoma. Exp Mol Med 2012; 44: 214-24.
34. Nakagawa S, Ip JY, Shioi G, Tripathi V, Zong X, Hirose T and Prasanth KV. Malat1 is not an essential component of nuclear speckles in mice. RNA 2012; 18: 1487-99.